Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

445 ARTÍCULOS , VIENDO DEL 61 AL 75

Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands

Iraji A, Khoshneviszadeh M, Firuzi O, Khoshneviszadeh M, Edraki N.

Bioorg Chem. 2020 Apr;97:103649. doi: 10.1016/j.bioorg.2020.103649. Epub 2020 Feb 4.

Overview of cannabidiol (CBD) and its analogues: Structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer's disease

Li H, Liu Y, Tian D, Tian L, Ju X, Qi L, Wang Y, Liang C.

Eur J Med Chem. 2020 Apr 15;192:112163. doi: 10.1016/j.ejmech.2020.112163. Epub 2020 Feb 22.

Postmortem Analysis in a Clinical Trial of AAV2-NGF Gene Therapy for Alzheimer's Disease Identifies a Need for Improved Vector Delivery

Castle MJ, Baltanás FC, Kovacs I, Nagahara AH, Barba D, Tuszynski MH.

Hum Gene Ther. 2020 Apr;31(7-8):415-422. doi: 10.1089/hum.2019.367. Epub 2020 Mar 30.

Alzheimer's disease: microglia targets and their modulation to promote amyloid phagocytosis and mitigate neuroinflammation

Anwar S, Rivest S.

Expert Opin Ther Targets. 2020 Apr;24(4):331-344. doi: 10.1080/14728222.2020.1738391. Epub 2020 Mar 12.

Learning from the Past: A Review of Clinical Trials Targeting Amyloid, Tau and Neuroinflammation in Alzheimer's Disease

Ceyzériat K, Zilli T, Millet P, Frisoni GB, Garibotto V, Tournier BB.

Curr Alzheimer Res. 2020;17(2):112-125. doi: 10.2174/1567205017666200304085513.

Drug Repositioning for Alzheimer's Disease: Finding Hidden Clues in Old Drugs

Ihara M, Saito S.

J Alzheimers Dis. 2020;74(4):1013-1028. doi: 10.3233/JAD-200049.

TV 3326 for Alzheimer's dementia: a novel multimodal ChE and MAO inhibitors to mitigate Alzheimer's-like neuropathology

Uddin MS, Kabir MT, Rahman MM, Mathew B, Shah MA, Ashraf GM.

J Pharm Pharmacol. 2020 Aug;72(8):1001-1012. doi: 10.1111/jphp.13244. Epub 2020 Mar 9.

Acetylcholinesterase: The "Hub" for Neurodegenerative Diseases and Chemical Weapons Convention

Cavalcante SFA, Simas ABC, Barcellos MC, de Oliveira VGM, Sousa RB, Cabral PAM, Kuča K, França TCC.

Biomolecules. 2020 Mar 7;10(3):414. doi: 10.3390/biom10030414.

Exploring the Promise of Targeting Ubiquitin-Proteasome System to Combat Alzheimer's Disease

Al Mamun A, Uddin MS, Kabir MT, Khanum S, Sarwar MS, Mathew B, Rauf A, Ahmed M, Ashraf GM.

Neurotox Res. 2020 Jun;38(1):8-17. doi: 10.1007/s12640-020-00185-1. Epub 2020 Mar 9.

Nanoparticlized System: Promising Approach for the Management of Alzheimer's Disease through Intranasal Delivery

Bahadur S, Sachan N, Harwansh RK, Deshmukh R.

Curr Pharm Des. 2020;26(12):1331-1344. doi: 10.2174/1381612826666200311131658.

Research Progress on Alzheimer's Disease and Resveratrol

Yan Y, Yang H, Xie Y, Ding Y, Kong D, Yu H.

Neurochem Res. 2020 May;45(5):989-1006. doi: 10.1007/s11064-020-03007-0. Epub 2020 Mar 11.

Insulin mediated novel therapies for the treatment of Alzheimer's disease

Dubey SK, Lakshmi KK, Krishna KV, Agrawal M, Singhvi G, Saha RN, Saraf S, Saraf S, Shukla R, Alexander A.

Life Sci. 2020 May 15;249:117540. doi: 10.1016/j.lfs.2020.117540. Epub 2020 Mar 10.

Extrapyramidal side effect of donepezil hydrochloride in an elderly patient: A case report

Li HC, Luo KX, Wang JS, Wang QX.

Medicine (Baltimore). 2020 Mar;99(11):e19443. doi: 10.1097/MD.0000000000019443.

Prevention of Cognitive Decline in Alzheimer's Disease by Novel Antioxidative Supplements

Tadokoro K, Ohta Y, Inufusa H, Loon AFN, Abe K.

Int J Mol Sci. 2020 Mar 13;21(6):1974. doi: 10.3390/ijms21061974.

[Pharmacological prevention of cognitive decline and dementia]

Jessen F.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 May;63(5):506-511. doi: 10.1007/s00103-020-03120-z.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias